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Abstract The kyphoscoliotic type of the Ehlers-Danlos syn-
drome (EDS VIA) is a rare recessively inherited connective
tissue disorder characterized by bruisable, hyperextensible skin,
generalized joint laxity, severe muscular hypotonia at birth and
progressive congenital scoliosis or kyphosis. Deficiency of the
enzyme lysyl hydroxylase 1 (LH1) due to mutations in PLOD1
results in underhydroxylation of collagen lysyl residues and,
hence, in the abnormal formation of collagen cross-links. Here,
we report on the clinical, biochemical, and molecular findings
in six Egyptian patients from four unrelated families severely
affected with EDS VIA. In addition to the frequently reported
p.Glu326_Lys585dup, we identified two novel sequence vari-
ants p.Gln208* and p.Tyr675*, which lead either to loss of
function of LH1 or to its deficiency. All affected children
presented with similar clinical features of the disorder, and in
addition, several dysmorphic craniofacial features, not yet de-
scribed in EDS VIA. These were specific for the affected
individuals of each family, but absent in their parents and their
unaffected siblings.
Conclusion: Our description of six patients presenting with
a homogeneous clinical phenotype and dysmorphic craniofa-
cial features will help pediatricians in the diagnosis of this rare
disorder.
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Introduction
The Ehlers-Danlos syndrome (EDS) is a genetically and clini-
cally heterogeneous group of connective tissue disorders which
have in common joint hypermobility, skin hyperextensibility, and
fragility [19]. The latest classification of EDS from 1998, the
Villefranche Nosology, recognizes six major subtypes, based on
the severity of the clinical symptoms, the pattern of inheritance
and the underlying biochemical and molecular defect [2].
Among them, the kyphoscoliotic type of the Ehlers-Danlos
syndrome (EDS VIA; OMIM 225400) is a rare autosomal
recessive disorder characterized by severe generalized muscular
hypotonia at birth, kyphoscoliosis which is progressive and
severe, marked joint hypermobility and luxations, and severe
skin hyperelasticity. In addition, there is fragility of the skin with
abnormal scarring, osteopenia, often a striking Marfanoid habi-
tus, microcorneae, bluish sclerae, and occasionally rupture of
arteries [2, 19]. The world-wide prevalence is estimated as low
as ∼1 in 100,000 live births [13, 15]. Additional variants of EDS
with distinct molecular and biochemical abnormalities, such as
musculocontractural-EDS (MS-EDS; OMIM #601776) and
FKBP14-EDS (OMIM 614547) have been recently identified
and have to be considered in the differential diagnosis of EDS
VIA [4].
EDS VIA is caused by mutations in procollagen-lysine, 2-
oxoglutarate 5-dioxygenase 1 (PLOD1; MIM 153454), which
encodes lysyl hydroxylase 1 (LH1; E.C. 1.14.11.4) [9]. This
enzyme catalyzes the formation of hydroxylysine in collagen
chains by the hydroxylation of lysine residues in Gly-X-Lys
sequences [10]. The hydroxylysine residues formed are essential
for the formation of intermolecular cross-links that provide the
collagen fibrils with their tensile strength and mechanical stabil-
ity, and serve as attachment sites for carbohydrate units [10]. The
enzyme deficiency gives rise to an abnormal urinary excretion
pattern of lysyl-pyridinolines (LP) and hydroxylysyl-
pyridinolines (HP) cross-links [16, 18]. Hence, the diagnosis of
EDS VIA relies on the demonstration of a markedly increased
ratio of total LP to HP (LP/HP) [5, 16, 18], and may then be
confirmed by finding either homozygous or compound hetero-
zygous disease causing variants in PLOD1. These are point
mutations, insertions, and deletions resulting in premature termi-
nation codons that lead to a deficiency of the enzyme LH1, while
only six different missense disease associated variants have been
described (according to the LOVD Gene Homepage for
PLOD1 at https://eds.gene.le.ac.uk/home.php?select_db=
PLOD1 ). The PLOD1 disease associated variants are mostly
private mutations identified in just one or few affected
individuals, with the exception of a large duplication between
exon 10 and exon 16 of PLOD1 (p.Glu326_Lys585dup). This
duplication, which is the most common of all reported mutations
[6, 15], occurs via homologous recombination of a 44-bp iden-
tical sequence located in a region of Alu repeats in introns 9 and
16 [7, 8, 14].
Here, we report the clinical, biochemical, and molecular
data of six EDS VIA patients from four unrelated Egyptian
families who shared a quite homogeneous clinical phenotype
in addition to dysmorphic craniofacial features. Finally, we
alert the physician to pay attention to facial dysmorphisms in
the diagnostic work-up of EDS VIA.
Materials and methods
We studied six individual patients from four unrelated
Egyptian families who manifested the characteristic clinical
features of EDSVIA. They were referred to one single genetic
center from 2010 until 2013 for further diagnostic investiga-
tions. Patients were subjected to clinical evaluation, biochem-
ical work-up of EDS VIA, and molecular analysis of PLOD1.
Clinical examination was performed by the same geneticist.
Total urinary pyridinolines were measured as described
[11] and were expressed as the ratio (LP/HP) of lysyl-
pyridinoline (LP) to hydroxylysyl-pyridinoline (HP).
Genomic DNAwas isolated from peripheral blood leuko-
cytes using standard techniques, and direct PCR and sequenc-
ing of PLOD1 was performed as described [6]. Two 4-day
lymphocyte cultures were established from 2-ml heparin-
blood sample from P3 in RPMI 1640 (Life Technologies)
medium containing phytohaemoagglutinin A (PHA) accord-
ing to Kretz et al. [13]. Before collection of the cells by
centrifugation, one culture was treated for 4 h with 200 mM
cycloheximide, in order to inhibit nonsense-mediated RNA
decay (NMD). Total RNA extraction and RT-PCR were per-
formed as previously described [6].
Results
The patient cohort consisted of three boys and three girls aged
6 months to 6 years, all born to consanguineous parents, belong-
ing to four unrelated Egyptian families. All families but one
includedmultiple affectedmembers (Fig. 1). All patients fulfilled
the major diagnostic criteria for EDS VIA (Table 1) except for
absence of scleral fragility and rupture of the ocular globe. They
all manifested most of the minor criteria, and presented addition-
ally dysmorphic craniofacial features not yet reported in the
literature in association with EDS VIA (Table 1 and Fig. 2).
Family 1 A 5-year-old girl (P1; Fig. 2 A-1–G-1), the first child
of healthy consanguineous Egyptian parents (Fig. 1), presented
for genetic evaluation of back deformity. Apart from weak fetal
movements, pregnancy was uneventful and delivery was at
term. At birth, severe muscular hypotonia, back deformity, and
adducted thumbs were noted. By the age of 2 years, the severe
muscular hypotonia had led to grossly delayed motor develop-
ment. At that age, she could hardly support her head. A
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neuromuscular work-up, including a brain CT, EMG, and NCV,
was normal. The patient began walking supported at the age of
3 years and only attained unsupported walking after her fourth
birthday. However, despite the markedly retarded motor devel-
opment, her neurological status and intellectual development
were normal. The family sought genetic consultation only after
the birth of a younger son who seemed to suffer from the same
condition.
The girl showed severe kyphoscoliosis and pectus
excavatum (Table 1). She had soft skin, hypermobile joints,
long hands with long hyperextensible fingers, interdigital
webbing, faint palmar creases, long toes, pes planus, and un-
usual plantar softness with doughy consistency of the heels.
The craniofacial features included faint synophrys, medial flare
of eyebrows, remarkable epicanthic folds and down-slanting
palpebral fissures, bluish sclerae, microcorneae, malar hypopla-
sia, depressed nasal bridges and upturned nostrils. The growth
parameters were within the normal range.
At examination, her 6-month-old brother (P2; Table 1)
presented with severe hypotonia, and was lying in a frog-
like position unable to support his head. Mild kyphoscoliosis,
pectus excavatum, adducted thumbs, abnormal palmar creases
and striking plantar softness were noted. He also had flat
supraorbital ridges, narrow almond-shaped palpebral fissures,
marked epicanthus inversus, and a small nose with upturned
nostrils.
An increased urinary pyridinoline ratio in P1 as well as
homozygosity for a PLOD1 c.622C>T (p.Gln208*) disease
causing variant in P1 and P2 confirmed the clinical diagnosis
(Table 2).
Family 2 Two sisters, aged 6 (P3) and 4 (P4) years, respec-
tively (patient P4 in Fig. 2 A-2–G-2; Table 1), were referred
for evaluation of skin fragility that was observed by the
surgeon during stitching of their recurrent skin lesions. They
were the second and third child of consanguineous parents
(Fig. 1), born at term by normal vaginal delivery. Pregnancy
was uneventful, apart from weak fetal movements reported by
the mother. Since birth, the mother noticed a peculiar doughy
skin consistency, severe hypotonia and poor sucking. In
Fig. 1 Pedigrees of the affected individuals showing the degree of inbreeding. The carriers are depicted as half-solid symbols, the patients as solid symbols
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addition, back deformity was noted in the first months of life.
Both girls also presented bilateral adducted thumbs, which
gradually improved and resolved by the age of 2 years. The
motor developmental milestones were severely delayed: they
began to sit up unsupported by the age of 2 years, and stood
alone at age 3 years. Their cognitive development was
normal. The girls presented with severe kyphoscoliosis,
joint hypermobility, mild skin hyperelasticity with abnor-
mal scarring, pectus excavatum, hypoplastic widely spaced
nipples and a protruding abdomen. Bluish sclerae,
microcorneae, arched eyebrows with marked medial flare
and synophrys were noted. In addition, the girls had long
hyperextensible fingers, interdigital webbing, palmar and
plantar softness, pes planus, rocker bottom heels, and a
striking hallux adductus (sandal gap deformity). Easy fati-
gability and poor exercise tolerance were reported by the
patients.
A significantly increased LP:HP ratio, as well as
homozygosity for a novel PLOD1 nonsense variant
p.Tyr675* (c.2025C>G) confirmed the suspected diagnosis
(Table 2).
RT-PCR on total RNA extracted from cultured lympho-
cytes of P3 demonstrated that this premature stop in exon 18
did not undergo NMD (Fig. 3).
Family 3 A 4-year-old boy (P5) was the first child of healthy
Egyptian first cousins parents (Fig. 1). He was born at term by
cesarean section because of a contracted pelvis. The parents
reported kyphoscoliosis from birth and severe hypotonia ac-
companied by severely delayed motor development: the pa-
tient could not sit until age 2 years and began walking after the
age of 3. Cognitive development was normal. A neuromuscu-
lar disorder was initially considered, however, neuromuscular
work-up was normal.
Clinical examination revealed (Fig. 2 A-3–G-3; Table 1)
severe kyphoscoliosis, pectus excavatum, hypoplastic widely
spaced nipples, protruding abdomen with a small umbilical
hernia, hypermobile joints, and soft skin with slightly in-
creased extensibility. Additionally facial asymmetry,
synophrys, marked epicanthic folds, microcorneae, and bluish
sclerae were noted. Hyperextensible long fingers with digital
Table 1 Clinical features of six patients affected with EDS VIA, and comparison with the major and minor criteria according to the Villefranche
Nosology [1]
Patients P1 P2 P3 P4 P5 P6
Age at investigation 5 years 6 months 6 years 4 years 4 years 3.5 years
Delivery NVD NVD NVD NVD CS NVD
Weight at birth in g 3250 3500 3200 3350 3000 3500
Length at birth in cm 52 56 54 52 53 55
Villefranche Nosology
Major criteria
Severe muscular hypotonia at birth + + + + + +
General joint laxity + + + + + +
Kyphoscoliosis at birth, progressive + + + + + +
Scleral fragility and rupture of the ocular globe − − − − − −
Minor criteria
Tissue fragility + + + + + +
Easy bruising + + + + + +
Arterial rupture − − − − − −
Marfanoid habitus + ? + + + +
Osteopeniaa n.e. n.e. + + + n.e.
Microcorneab (corneal diameter) + (10mm) + (n.e.) + (10.5mm) + (10.5mm) + (9.5mm) + (9mm)
Additional clinical signs
Craniofacial dysmorphisms + + + + + +
Adducted thumb bilateral + + + + + +
NVD normal vaginal delivery, CS cesarean section, + the feature is present, − the feature is absent, n.e. not estimated, ? unclear
aOsteopenia assessed on X-rays
b In normal individuals the corneal diameter is approximately 11.7 mm (range 11.0–12.5) [17]
Fig. 2 Similar clinical features of Egyptian patients affected with EDS
VIA: Multiple atrophic scars on foreheads and microcorneae [white
arrows; A-1–4, front view; B-1–4, lateral view], joint hypermobility [C-
1–4], pectus excavatum and hypoplastic, widely spaced nipples [D-1–4],
kyphoscoliosis and prominent abdomen [E-1–4], abnormal scarring on
knees [F-1–3] and elbows [F-4] and pes planus with rocker bottom heel
[G-1–4]
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webbing, pes planus, soft soles, and rocker bottom heels were
also noted. The patient manifested multiple abnormal atrophic
scars all over his body, which, as the mother claimed, had
developed after skin injuries induced by minor trauma after
the age of 2 years.
After confirming the diagnosis of EDS VIA through the
analysis of total urinary pyridinolines, homozygosity for the
common large duplication between exon 10 and exon 16 of
PLOD1 was detected (Table 2).
Family 4 A 3.5-year-old boy (P6) born to consanguineous
Egyptian parents presented with progressive kyphoscoliosis.
He was born at term by vaginal delivery after an uneventful
pregnancy. At birth, he was very floppy and back deformity
was noticed. Over the years, this deformity became more
pronounced and hypotonia persisted leading to motor devel-
opmental delay. In fact, he achieved unsupported walking
only after the age of 3 years. His parents also complained
about skin fragility with easy bruising and poor scar forma-
tion. The patient had a similarly affected sibling who suffered
from repeated chest infections and died at the age of 4 months
for unknown reasons (Fig. 1).
At examination, the patient (Fig. 2 A-4–G-4) showed a
prominent high forehead and frontal upsweep of anterior
hairline, hypoplastic supraorbital ridges, and marked malar
hypoplasia. Striking hypertelorism with epicanthic folds,
down-slanting palpebral fissures, faint synophrys and
microcorneae were also noted. The nose had a very broad
root, a depressed bridge, and a blunt tip. He presented with
mild pectus excavatum, hypoplastic widely spaced nipples,
pes planus, rocker bottom heels, marked plantar softness, and
hallux adductus. Multiple atrophic scars were noticed on the
forehead, the lower back, and both elbows and knees. All
anthropometric measurements were within average parame-
ters and the cognitive status was normal.
A markedly increased LP:HP ratio and presence of the
homozygous PLOD1 exon 10–exon 16 duplication confirmed
the suspected clinical diagnosis (Table 2).
Discussion
Major and minor diagnostic criteria for the kyphoscoliosis
type of EDS (EDS VIA) have been defined by the Ville-
franche Nosology in 1998 [2]. The first include generalized
joint laxity, severe muscle hypotonia at birth, scoliosis at birth
which is progressive, fragility of the sclerae with occasional
rupture of the ocular globe. The minor diagnostic criteria
include tissue fragility, easy bruisability of the skin with
atrophic scar formation (Fig. 2 A-1–4 and F-1–4), arterial
rupture, Marfanoid habitus, microcorneae, and osteopenia.
The Egyptian patient cohort presented here calls attention
to the strikingly homogenous clinical phenotype (Table 1).
Table 2 Biochemical and molecular findings in six patients diagnosed with EDS VIA. In all parents, heterozygosity for the corresponding PLOD1
mutation was proven
Family and patient numbers LP:HP ratioa Homozygous mutations in PLOD1
Family 1 (P1 and P2) 6.00 (P1)b p.Gln208* (c.622C>T)
Family 2 (P3 and P4) 3.88 and 3.89 p.Tyr675* (c.2025C>G)
Family 3 (P5) 6.25 p.Glu326_Lys585dup (c.1067_1546dup)
Family 4 (P6) 7.28 p.Glu326_Lys585dup (c.1067_1546dup)
aLP:HP normal range is 0.158–0.218 (n=83; age 1 months to 14 years) [11]
bUrine sample of P2 not available
Fig. 3 RT-PCR on total RNA extracted from cultured lymphocytes of a
normal control (lane 2), P3 without CHX (lane 3) (a), and P3 with CHX
(lane 4); andWTsequencing of PLOD1 between exon 13 and exon 19 in
P3 (b). Efficient amplification of the exon 13-exon 19 sequence and
homozygosity for the c.2025C>G pathologic variant in the RNA sample
obtained without CHX treatment, indicates that the mutant PLOD1
transcript escapes NMD
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They all manifested severe neonatal muscular hypotonia, con-
genital progressive kyphoscoliosis (Fig. 2 E-1–4), pectus
excavatum (Fig. 2 D-1–4), severe joint hypermobility (Fig. 2
C-1–4) and pes planus with rocker bottom heel (Fig. 2 G-1–4),
microcorneae and dysmorphic craniofacial features (Fig. 2
A-1–4, front view; B-1–4, lateral view). Osteopenia was a
less common feature, being identified in about half of the
probands. None of the patients had suffered yet any compli-
cations related to arterial rupture, or scleral fragility. Normal
cognitive development and normal intellectual ability were
documented in the patients.
Congenital severe hypotonia accompanied by muscular
weakness led, in all probands, to a severe impairment in
achieving age-related developmental milestones, and before
the present examination was done, it prompted a neuromus-
cular work-up which gave negative results. Although it is
known that neonatal muscular hypotonia in the first years of
life leads to a delay in gross motor development in infants
affected with EDS VIA, and should prompt the noninvasive
investigation of urinary pyridinolines [6, 16, 20], the oldest
patients of our cohort were suspected in infancy to suffer from
a congenital myopathy. Therefore, they underwent an invasive
neuromuscular work-up which gave normal results.
Literature reports on long-term outcome of ambulation in
patients with EDSVIA are scarce. Rohrbach et al. [16] reported
data on six patients aged 4 to 27 years, showing that all but one
patient, who was wheel chair bound, could either walk inde-
pendently or with assistance. The patients presented here could
achieve unsupported walking by an average age of 4 years.
Skin fragility with easy bruising, recurrent cuts on minor
trauma, and abnormal scarring (Fig. 2 F-1–4) were invariable
complaints of the patients. Velvety skin texture, a feature
previously described [16] was absent. However, extreme plan-
tar softness and doughy consistency of the heels, were noted
in all patients, and were reported by the parents to be more
pronounced in the neonatal period and in early infancy.
Apart from down-slanting palpebral fissures, a feature re-
ported occasionally in the literature [20], there are scarce
reports on craniofacial features in EDS VIA patients. All our
patients showed dysmorphic craniofacial features (Fig. 2 and
Table 1) which were absent in their parents as well as in their
unaffected siblings.
Despite being considered a minor diagnostic criterion for
EDS VIA, microcorneae [2] was present in all affected chil-
dren, but not in their unaffected siblings. In the contrary,
despite being considered a major diagnostic criterion accord-
ing to the Villefranche Nosology, scleral fragility with occa-
sional rupture of the ocular globe was not documented in any
of our patients. To the best of our knowledge (search in OMIM
and PubMed), there are only four reports in the literature of
ocular fragility accompanied by either retinal detachment or
rupture of the ocular globe: a male patient presenting with
rhegmatogenous retinal detachment in his left eye at the age of
47 years, and accidental rupture of the ocular globe with
subsequent enucleation of the right eye at the age of 9 years
[3]; a female patient who suffered from enucleation of her left
eye after a car accident [12]; two siblings who presented with
fragility of ocular tissues leading to rupture of the globe or
retinal detachment in adult age [1].
Although unusual for EDS VIA, bilateral adducted thumb,
which was noted during examination of the two infant pa-
tients, was a common finding in all affected children in
infancy, and according to their parents it resolved spontane-
ously by the age of 2 years.
For prenatal purposes, mutational analysis of PLOD1 was
performed (Table 2).
In two patients (P5 and P6) from two unrelated families,
homozygosity for the common large duplication of exons 10
to 16 (c.1067_1546dup; p.Glu326_Lys585dup) was detected.
In patients P1 and P2, we identified a novel PLOD1 disease
causing variant in exon 6 (c.622C>T, p.Gln208*) which is
expected to lead to complete deficiency of LH1 because of
NMD. The second novel nonsense variant p.Tyr675*
(c.2025C>G in exon 15), which was found in homozygosity
in patients P3 and P4, is localized close to the naturally
occurring stop codon in exon 19, and escapes NMD as shown
by RT-PCR (Fig. 3). Therefore, p.Tyr675* is expected to lead
to a shorter enzyme protein missing the 2-oxoglutarate
dioxygenase and the iron-binding domains essential for its
catalytic activity. If the shorter enzyme protein preserves
partial activity is unclear, although the relatively low LP:HP
ratios measured on both siblings (3.88 and 3.89; Table 2)
might support this hypothesis; however, the low LP:HP ratios
recorded in these severely affected sisters suggest a lack of
correlation between the severity of the phenotype and the
urinary LP:HP value.
The high degree of inter- and intrafamilial phenotypic
variability among individuals affected with EDS VIA and
lack of an obvious genotype-phenotype correlation has been
well documented [6, 16, 19]. Our report on six patients shar-
ing similar clinical features and nearly absent intrafamilial
variability seems to contradict these previous reports. It is
tempting to hypothesize that frequent consanguineous mar-
riages leading to a less heterogeneous genetic pool, in addition
to the same ethnic background, partially contributes to the
documented phenotypic similarity in our cohort of EDS VIA
patients.
In conclusion, here, we show that six EDS VIA affected
children from four unrelated Egyptian families, who are ho-
mozygous for PLOD1 mutations leading either to loss of
function of LH1 or to its deficiency, presented all with similar
phenotypical features and craniofacial dysmorphisms not yet
reported in the literature. Two new PLOD1-disease causing
variants, p.Gln208* and p.Tyr675*, were identified. To the
best of our knowledge, this is not only the first report of EDS
VIA cases from Egypt, but also the first report on so many
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cases sharing the same ethnic background. Finally, we pro-
pose to consider craniofacial dysmorphisms as possible addi-
tional clinical features of EDS VIA that may help the pedia-
trician in recognizing this rare disorder.
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